Alex Thurman
Director of Finance/CFO at GLAUKOS CORPORATION
Net worth: 5 M $ as of 2024-03-30
Profile
Alex Thurman is currently the Chief Financial Officer & Senior Vice President at Glaukos Corp.
and the Vice President-Finance at Allergan Ltd.
(Ireland).
He has an undergraduate and graduate degree from Brigham Young University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GLAUKOS CORP
0.11% | 2024-04-07 | 52,532 ( 0.11% ) | 5 M $ | 2024-03-30 |
Alex Thurman active positions
| Companies | Position | Start |
|---|---|---|
| GLAUKOS CORPORATION | Director of Finance/CFO | 2022-03-31 |
| ALLERGAN PLC | Director of Finance/CFO | 2016-11-30 |
Training of Alex Thurman
| Brigham Young University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GLAUKOS CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Alex Thurman
